{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:40:49Z","timestamp":1784634049579,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.semnephrol.2017.07.003","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T08:30:11Z","timestamp":1509093011000},"page":"508-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Brief History of APOL1 : A Gene Evolving"],"prefix":"10.1016","volume":"37","author":[{"given":"David J.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2017.07.003_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature01461","article-title":"Apolipoprotein L-I is the trypanosome lytic factor of human serum","volume":"422","author":"Vanhamme","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib4","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI46263","article-title":"Genetics of kidney failure and the evolving story of APOL1","volume":"121","author":"Friedman","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.085647.108","article-title":"The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions","volume":"19","author":"Smith","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4161\/viru.3.1.18295","article-title":"Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors","volume":"3","author":"Bullard","year":"2012","journal-title":"Virulence"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib8","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1128\/IAI.67.4.1910-1916.1999","article-title":"Characterization of a novel trypanosome lytic factor from human serum","volume":"67","author":"Raper","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib9","doi-asserted-by":"crossref","first-page":"32578","DOI":"10.1074\/jbc.M503510200","article-title":"Human high density lipoproteins are platforms for the assembly of multi-component innate immune complexes","volume":"280","author":"Shiflett","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molbiopara.2004.07.004","article-title":"Characterization of primate trypanosome lytic factors","volume":"138","author":"Lugli","year":"2004","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib11","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1681\/ASN.2011050519","article-title":"Population-based risk assessment of APOL1 on renal disease","volume":"22","author":"Friedman","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib12","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1056\/NEJMoa063265","article-title":"Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I","volume":"355","author":"Vanhollebeke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib13","doi-asserted-by":"crossref","first-page":"e51546","DOI":"10.1371\/journal.pone.0051546","article-title":"APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis","volume":"7","author":"Johnstone","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib15","doi-asserted-by":"crossref","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib16","doi-asserted-by":"crossref","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib17","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yexmp.2015.03.020","article-title":"Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu","volume":"98","author":"Lan","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib18","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.20071463","article-title":"Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model","volume":"205","author":"Molina-Portela","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib19","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1074\/jbc.M900151200","article-title":"Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein","volume":"284","author":"Harrington","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.1156296","article-title":"A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans","volume":"320","author":"Vanhollebeke","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib21","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1126\/science.1114566","article-title":"Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes","volume":"309","author":"Perez-Morga","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib22","doi-asserted-by":"crossref","first-page":"8078","DOI":"10.1038\/ncomms9078","article-title":"Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1","volume":"6","author":"Vanwalleghem","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib23","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molbiopara.2005.08.018","article-title":"Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes","volume":"144","author":"Molina-Portela Mdel","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","article-title":"A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense","volume":"95","author":"Xong","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib26","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature12516","article-title":"Mechanism of Trypanosoma brucei gambiense resistance to human serum","volume":"501","author":"Uzureau","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib27","doi-asserted-by":"crossref","first-page":"e1003317","DOI":"10.1371\/journal.ppat.1003317","article-title":"A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding","volume":"9","author":"DeJesus","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib28","doi-asserted-by":"crossref","first-page":"e1728","DOI":"10.1371\/journal.pntd.0001728","article-title":"Trypanosoma brucei gambiense group 1 is distinguished by a unique amino acid substitution in the HpHb receptor implicated in human serum resistance","volume":"6","author":"Symula","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib29","doi-asserted-by":"crossref","first-page":"16137","DOI":"10.1073\/pnas.1007074107","article-title":"Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor","volume":"107","author":"Kieft","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ajhg.2013.05.014","article-title":"Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations","volume":"93","author":"Ko","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib31","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nature01140","article-title":"Detecting recent positive selection in the human genome from haplotype structure","volume":"419","author":"Sabeti","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib33","doi-asserted-by":"crossref","first-page":"19509","DOI":"10.1073\/pnas.0905669106","article-title":"Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes","volume":"106","author":"Thomson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib34","first-page":"39","article-title":"Infectivity of Trypanosoma (Trypanozoon) brucei gambiense for baboons (Papio hamadryas, Papio papio)","volume":"71","author":"Kageruka","year":"1991","journal-title":"Ann Soc Belg Med Trop"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib35","doi-asserted-by":"crossref","unstructured":"Cooper A, Ilboudo H, Alibu VP, Ravel S, et al. APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypansomiasis. Elife 2017 May 24. PMID 28537557.","DOI":"10.7554\/eLife.25461"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02198-15","article-title":"Apolipoprotein L1 variant associated with increased susceptibility to Trypanosome infection","volume":"7","author":"Cuypers","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib37","doi-asserted-by":"crossref","first-page":"e1000276","DOI":"10.1371\/journal.ppat.1000276","article-title":"Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection","volume":"5","author":"Samanovic","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib38","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1681\/ASN.2014050469","article-title":"APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans","volume":"26","author":"Kasembeli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib39","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0272-6386(00)70055-2","article-title":"Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis","volume":"35","author":"Tanawattanacharoen","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib40","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1046\/j.1523-1755.2001.00727.x","article-title":"Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy","volume":"59","author":"Moudgil","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2017.07.003_bib41","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1128\/JVI.02828-13","article-title":"The innate immune factor apolipoprotein L1 restricts HIV-1 infection","volume":"88","author":"Taylor","year":"2014","journal-title":"J Virol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T16:32:46Z","timestamp":1603211566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929517300694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0270929517300694"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.07.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Brief History of APOL1: A Gene Evolving","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}